NO20080637L - Fremgangsmate for behandling eller forebygging av tilstander forarsaket av gram-positive bakterier - Google Patents
Fremgangsmate for behandling eller forebygging av tilstander forarsaket av gram-positive bakterierInfo
- Publication number
- NO20080637L NO20080637L NO20080637A NO20080637A NO20080637L NO 20080637 L NO20080637 L NO 20080637L NO 20080637 A NO20080637 A NO 20080637A NO 20080637 A NO20080637 A NO 20080637A NO 20080637 L NO20080637 L NO 20080637L
- Authority
- NO
- Norway
- Prior art keywords
- gram
- positive bacteria
- treating
- conditions caused
- preventing conditions
- Prior art date
Links
- 241000192125 Firmicutes Species 0.000 title abstract 2
- 206010051379 Systemic Inflammatory Response Syndrome Diseases 0.000 abstract 3
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 abstract 2
- 230000004768 organ dysfunction Effects 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- 206010053159 Organ failure Diseases 0.000 abstract 1
- 206010040047 Sepsis Diseases 0.000 abstract 1
- 206010040070 Septic Shock Diseases 0.000 abstract 1
- 239000003613 bile acid Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- 150000003904 phospholipids Chemical class 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 230000036303 septic shock Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71207505P | 2005-08-29 | 2005-08-29 | |
| PCT/US2006/033581 WO2007027636A2 (en) | 2005-08-29 | 2006-08-25 | Method for treatment or prevention of conditions caused by gram-positive bacteria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20080637L true NO20080637L (no) | 2008-03-26 |
Family
ID=37809418
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20080637A NO20080637L (no) | 2005-08-29 | 2008-02-05 | Fremgangsmate for behandling eller forebygging av tilstander forarsaket av gram-positive bakterier |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20070049554A1 (pt) |
| EP (1) | EP1933856A4 (pt) |
| JP (1) | JP5432525B2 (pt) |
| KR (1) | KR101413361B1 (pt) |
| CN (1) | CN101252942B (pt) |
| AP (1) | AP2626A (pt) |
| AU (1) | AU2006284990B2 (pt) |
| BR (1) | BRPI0615411A2 (pt) |
| CA (1) | CA2621066C (pt) |
| NO (1) | NO20080637L (pt) |
| NZ (1) | NZ565590A (pt) |
| RU (1) | RU2391985C2 (pt) |
| UA (1) | UA89545C2 (pt) |
| WO (1) | WO2007027636A2 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2486371A (en) | 2009-08-21 | 2012-06-13 | Targeted Delivery Technologies Ltd | Vesicular formulations |
| GB201205642D0 (en) | 2012-03-29 | 2012-05-16 | Sequessome Technology Holdings Ltd | Vesicular formulations |
| US9023833B2 (en) * | 2012-12-18 | 2015-05-05 | Sepsicure, LLC | Method for treating sepsis in patients with albumin, cholesterol and HDL levels above minimum thresholds |
| HK1219228A1 (zh) * | 2013-03-15 | 2017-03-31 | 制药创源有限公司 | 雷公藤甲素静脉注射乳剂用作免疫调制剂和抗癌药 |
| EP2805612A1 (en) | 2013-05-22 | 2014-11-26 | University of Graz | Lysophospholipids against American Foulbrood |
| US10744090B2 (en) | 2015-06-30 | 2020-08-18 | Sequessome Technology Holdings Limited | Multiphasic compositions |
| BR112022019511A2 (pt) * | 2020-04-03 | 2022-11-16 | Vivacelle Bio Inc | Composições e métodos para tratar ou prevenir síndrome de disfunção de múltiplos órgãos |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2220331A (en) * | 1936-02-28 | 1940-11-05 | Schering Corp | Remedy for infection by cocci and process of manufacturing it |
| US4072575A (en) * | 1976-05-03 | 1978-02-07 | Mcdonnell Douglas Corporation | Broth and method for detecting E. coli in mixed water samples |
| US4340671A (en) * | 1977-08-29 | 1982-07-20 | Mcdonnell Douglas Corporation | E. coli sensitivity broth |
| JPS61172826A (ja) * | 1985-01-25 | 1986-08-04 | Tanabe Seiyaku Co Ltd | 魚類連鎖球菌症の予防・治療用組成物 |
| JPS6259214A (ja) * | 1985-09-09 | 1987-03-14 | Kyowa Yakuhin Kk | 水生動物感染症起因菌の抗菌剤 |
| NO178843C (no) * | 1988-07-11 | 1996-06-19 | Sspl Sa Safe Sex Prod Licens | Fremgangsmåte for fremstilling av et farmasöytisk preparat for å forhindre seksuelt overförbare sykdommer |
| JPH0672882A (ja) * | 1991-07-29 | 1994-03-15 | Sennosuke Tokumaru | インターフェロン−β産生増強剤 |
| US6306621B1 (en) * | 1991-11-18 | 2001-10-23 | The United States Of America As Represented By The Administrator Of The U.S. Environmental Protection Agency | Membrane filter agar medium for simultaneous detection of total coliforms and E. coli |
| US5344822A (en) * | 1992-08-12 | 1994-09-06 | The Rogosin Institute | Methods useful in endotoxin prophylaxis and therapy |
| US5674855A (en) * | 1992-08-12 | 1997-10-07 | The Rogosin Institute | Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions |
| US5587366A (en) * | 1992-08-12 | 1996-12-24 | The Rogosin Institute | Compositions useful in prophylaxis and therapy of endotoxin related conditions |
| JPH07277986A (ja) * | 1994-04-08 | 1995-10-24 | Kazuo Hosoya | 胆汁酸塩を主成分とするメチシリン耐性黄色ブドウ球菌用抗菌 剤成分 |
| US5932536A (en) * | 1994-06-14 | 1999-08-03 | The Rockefeller University | Compositions for neutralization of lipopolysaccharides |
| JPH1017476A (ja) * | 1996-06-28 | 1998-01-20 | Nippon Seiyaku Kk | 敗血症用非経口製剤及びそれによる予防及び治療方法 |
| US6165997A (en) * | 1997-11-20 | 2000-12-26 | Statens Serum Institut | Phospholipids having antimicrobial activity with or without the presence of antimicrobials |
| US9040078B2 (en) * | 2000-01-10 | 2015-05-26 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of lipid conjugates in the treatment of diseases of the nervous system |
| US7811999B2 (en) * | 2000-01-10 | 2010-10-12 | Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. | Use of lipid conjugates in the treatment of diseases |
| CU22789A1 (es) * | 2000-06-29 | 2002-07-24 | Ct Nac Biopreparados | Mezcla nutritiva y procedimiento para la identificación y recuento temprano de organismos gram-negativos |
| US7758893B2 (en) * | 2001-07-27 | 2010-07-20 | N.V. Nutricia | Enteral compositions for the prevention and/or treatment of sepsis |
| US20030032674A1 (en) * | 2001-08-13 | 2003-02-13 | Hwang Daniel H. | Use of unsaturated fatty acids to treat severe inflammatory diseases |
| US20030143658A1 (en) * | 2002-01-28 | 2003-07-31 | Casella Linda J. Richardson | Rapid methods and devices for the detection of coliform and the detection and confirmation of E. coil |
| US20080318870A1 (en) * | 2007-06-19 | 2008-12-25 | Kythera Biopharmaceuticals, Inc. | Synthetic bile acid compositions and methods |
-
2006
- 2006-08-25 BR BRPI0615411-5A patent/BRPI0615411A2/pt not_active Application Discontinuation
- 2006-08-25 AU AU2006284990A patent/AU2006284990B2/en not_active Ceased
- 2006-08-25 US US11/510,094 patent/US20070049554A1/en not_active Abandoned
- 2006-08-25 RU RU2008111897/14A patent/RU2391985C2/ru not_active IP Right Cessation
- 2006-08-25 JP JP2008529172A patent/JP5432525B2/ja not_active Expired - Fee Related
- 2006-08-25 AP AP2008004344A patent/AP2626A/xx active
- 2006-08-25 CA CA2621066A patent/CA2621066C/en active Active
- 2006-08-25 WO PCT/US2006/033581 patent/WO2007027636A2/en not_active Ceased
- 2006-08-25 CN CN200680031406XA patent/CN101252942B/zh not_active Expired - Fee Related
- 2006-08-25 NZ NZ565590A patent/NZ565590A/en not_active IP Right Cessation
- 2006-08-25 KR KR1020087005056A patent/KR101413361B1/ko not_active Expired - Fee Related
- 2006-08-25 EP EP06813861A patent/EP1933856A4/en not_active Ceased
- 2006-08-25 UA UAA200801080A patent/UA89545C2/uk unknown
-
2008
- 2008-02-05 NO NO20080637A patent/NO20080637L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR101413361B1 (ko) | 2014-06-27 |
| US20070049554A1 (en) | 2007-03-01 |
| BRPI0615411A2 (pt) | 2012-12-04 |
| RU2391985C2 (ru) | 2010-06-20 |
| CA2621066C (en) | 2011-11-29 |
| NZ565590A (en) | 2010-07-30 |
| RU2008111897A (ru) | 2009-10-10 |
| CN101252942B (zh) | 2010-12-22 |
| KR20080066914A (ko) | 2008-07-17 |
| EP1933856A4 (en) | 2008-11-19 |
| WO2007027636A2 (en) | 2007-03-08 |
| JP5432525B2 (ja) | 2014-03-05 |
| UA89545C2 (uk) | 2010-02-10 |
| HK1115325A1 (en) | 2008-11-28 |
| CA2621066A1 (en) | 2007-03-08 |
| JP2009506120A (ja) | 2009-02-12 |
| AU2006284990B2 (en) | 2011-01-06 |
| EP1933856A2 (en) | 2008-06-25 |
| AU2006284990A1 (en) | 2007-03-08 |
| CN101252942A (zh) | 2008-08-27 |
| WO2007027636A3 (en) | 2007-09-07 |
| AP2626A (en) | 2013-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20053845L (no) | Gyraseinhibitorer og anvendelser derav | |
| NO20074666L (no) | Imidazo(1,2-A)pyridinforbindelser som VEGF-R2-inhibitorer | |
| DK2164331T3 (da) | Borholdige små molekyler | |
| BRPI0506629A (pt) | inibição do fator b, a via alternativa do sistema complemento e métodos relacionados | |
| NO20050099L (no) | 2-ureido-6-heteroaryl-3H-benzoimidazol-4-karboksylsyrederivater og relaterte forbindelser sa som gyrase- og/eller topoisomerase IV-inhibitorer for behandling av bakterielle infeksjoner | |
| NO20064120L (no) | 3-'4-heterocyklyl-1,2,3,-triazol-l-yll-N-aryl-benzamid er som inhibitorer av cytokinproduksjon for behandling av kroniske inflammatoriske sykdommer | |
| ATE433980T1 (de) | Gyraseinhibitoren und deren verwendungen | |
| ATE495743T1 (de) | Triazolopyridinverbindungen zur behandlung von degenerations- und entzündungskrankheiten | |
| NO20082509L (no) | Pyridopyrazinderivater og deres anvendelse | |
| WO2006133396A3 (en) | Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (pd-1) pathway | |
| CY1114038T1 (el) | Παραγωγα ιμιδαζοπυριδινης τα οποια αναστελλουν την εκκριση γαστρικου οξεος | |
| EA200900613A1 (ru) | Спирокетоновые ингибиторы ацетил-коа-карбоксилаз | |
| NO20076412L (no) | Heterosykliske inhibitorer av mek og fremgangsmater for anvendelse derav | |
| TW200638933A (en) | Compounds for inflammation and immune-related uses | |
| NO20073849L (no) | Indolderivater for behandling av virale infeksjoner | |
| ATE433988T1 (de) | Phosphoramidatderivate | |
| NO20090171L (no) | Substituerte aminopyrazolpyridiner og salter derav, fremgangsmate for fremstilling av slike, og farmasoytiske preparater inneholdende slike | |
| WO2018017368A9 (en) | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING A SYMPTOM ASSOCIATED WITH GUT OR HYPERURICEMIA | |
| NO20074084L (no) | Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikamenter og medikamenter inneholdende disse | |
| NO20082396L (no) | Fremgangsmater for behandling av mave-tarmkanalinfeksjoner med tigecyclin | |
| EA201070504A1 (ru) | КАРБАЦЕФЕМ β-ЛАКТАМОВЫЕ АНТИБИОТИКИ | |
| CY1117379T1 (el) | Παραγωγα ιμιδαζολιου ως αναστολεις toy tafi-a | |
| MY140903A (en) | Imidazole derivatives used as tafia inhibitors | |
| WO2007027636A3 (en) | Method for treatment or prevention of conditions caused by gram-positive bacteria | |
| NO20092246L (no) | Urea og sulfamidderivater som tafiainhibitorer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |